Internal Medicine, Pulmonary Disease · Edmond, OK
NPI
1396891743
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
105 So. Bryant Ave, Suite 104
Edmond, OK, 73034
Phone (405) 715-2022
Groups this clinician bills Medicare through
Medicare paid, 2024
$133K
1,759 services
Medicare patients, 2024
618
Average age 74
Drug cost, 2024
$2.3M
3,221 prescriptions
Company payments, 2025
$878
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael S Hull was code 99215 (office e&m - established), 481 times for 309 patients. In total Michael S Hull billed 1,759 services in 45 codes, and Medicare paid $133K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-03-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 481 | 309 | $111.82 | $54K |
| 94010 Pulmonary Function Testing | Office | 254 | 232 | $16.05 | $4,077 |
| 99214 Office E&M - Established | Office | 221 | 200 | $77.33 | $17K |
| 99233 Hospital E&M - Subsequent | Facility | 197 | 83 | $79.44 | $16K |
| 99291 Critical Care E&M | Facility | 70 | 26 | $143.75 | $10K |
| 99223 Hospital E&M - Initial | Facility | 70 | 67 | $112.14 | $7,850 |
| 99205 Office E&M - New | Office | 69 | 69 | $141.25 | $9,746 |
| 94729 Pulmonary Function Testing | Facility | 67 | 67 | $5.93 | $397 |
| 94727 Pulmonary Function Testing | Facility | 45 | 45 | $7.98 | $359 |
| 94375 Pulmonary Function Testing | Facility | 37 | 37 | $9.65 | $357 |
| 99204 Office E&M - New | Office | 30 | 30 | $99.72 | $2,992 |
| 99232 Hospital E&M - Subsequent | Facility | 28 | 24 | $53.22 | $1,490 |
| 99213 Office E&M - Established | Office | 24 | 23 | $58.41 | $1,402 |
| 94060 Pulmonary Function Testing | Facility | 22 | 22 | $6.88 | $151 |
| 31624 Bronchoscopy | Facility | 16 | 16 | $50.47 | $808 |
By year: 2022 $162K for 1,863 services; 2023 $168K for 1,991 services; 2024 $133K for 1,759 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael S Hull prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 416 prescriptions and refills. In total Michael S Hull wrote 3,221 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 416 | 701 | 97 | $439K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 283 | 369 | 101 | $11K |
| Azithromycin Generic | 254 | 535 | 102 | $8,211 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 232 | 368 | 61 | $224K |
| Prednisone Generic | 175 | 236 | 92 | $774 |
| Breo Ellipta Fluticasone/Vilanterol | 159 | 241 | 39 | $94K |
| Montelukast Sodium Generic | 153 | 419 | 46 | $2,730 |
| Fluticasone Propionate Generic | 135 | 271 | 53 | $2,282 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 87 | 176 | 23 | $81K |
| Ventolin Hfa Albuterol Sulfate | 87 | 106 | 28 | $7,771 |
| Spiriva Respimat Tiotropium Bromide | 73 | 122 | 19 | $61K |
| Omeprazole Generic | 55 | 145 | 25 | $1,120 |
| Roflumilast Generic | 47 | 83 | Under 11 | $2,120 |
| Symbicort Budesonide/Formoterol Fumarate | 46 | 88 | 21 | $19K |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 46 | 61 | 13 | $33K |
Brand drugs: - claims; generic drugs: 1,612 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael S Hull $878 ($878 in general payments such as food, travel and fees) from 14 companies. The largest payer was GlaxoSmithKline, LLC. with $154.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 18 | $154 |
| Baxter Healthcare BAX | 5 | $111 |
| Genzyme Corporation SNY | 4 | $96.53 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $71.4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $71.15 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $68.87 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $68.23 |
| Inogen, Inc. INGN | 4 | $65.98 |
| Insmed, Inc. INSM | 2 | $63.06 |
| Merck Sharp & Dohme LLC MRK | 2 | $36.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.